Related Experiment Videos
Stakeholder Perspectives on Cancer Survivors' Return to Work and Well-Being: Qualitative Interview Study
Sara L Fällman1,2, Katarina Wijk3,4,5, Anna Efverman1
1Department of Caring Science, Faculty of Health and Occupational Studies, University of Gävle, Kungsbäcksvägen 47, Gävle, Gävleborg, 801 76, Sweden, 46 707305930.
JMIR Cancer
|May 11, 2026
Summary
Returning to work after cancer treatment is challenging. Improved collaboration, clear roles, and flexible support are crucial for successful cancer survivor reintegration and well-being.
Area of Science:
- Oncology
- Occupational Health
- Rehabilitation Medicine
Background:
- Cancer affects a significant portion of the working population, necessitating effective return-to-work (RTW) strategies.
- Improving cancer survival rates leads to more individuals needing support for work reintegration post-treatment.
- Existing rehabilitation frameworks often fall short in addressing the barriers faced by cancer survivors in sustainable employment.
Purpose of the Study:
- To explore stakeholder perspectives on facilitators and barriers to return-to-work (RTW) for cancer survivors.
- To identify factors that promote work-related well-being during the RTW process for cancer patients.
- To inform the development of a work-oriented rehabilitation intervention.
Main Methods:
- Qualitative content analysis of semistructured interviews with 25 stakeholders.
- Stakeholders included healthcare professionals, social insurance officers, employers, and employment service officers.
- Interviews were conducted during the development phase of a work-oriented rehabilitation intervention.
Main Results:
- Five themes emerged: collaboration, individual adaptations, structural support, individual expectations, and the emotional significance of work.
- Facilitators included flexible work, individualized support, strong work desire, and the value of work.
- Barriers involved poor collaboration, unclear responsibilities, and structural issues like sick leave bureaucracy and financial obstacles.
Conclusions:
- Return-to-work for cancer survivors is complex, requiring coordinated efforts across healthcare, insurance, and employment sectors.
- Enhanced collaboration, defined stakeholder roles, and flexible, individualized support are vital for successful RTW.
- A dedicated coordinator role and early RTW support are proposed to prevent long-term labor market exclusion.
Related Concept Videos
Cancer Survival Analysis
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
Nursing Ethical Principles II
Ethical principles are essential in guiding nurses to fulfill their responsibilities, focusing on the quality of nursing care and decision-making. These principles, including autonomy, beneficence, non-maleficence, justice, and fidelity, shape the ethical framework within healthcare settings.
Consider the following scenario, which illustrates how these principles are applied in the care of Mr. John, a fifty-year-old teacher diagnosed with metastatic liver cancer.
Initially, Mr. John's cancer...
Consider the following scenario, which illustrates how these principles are applied in the care of Mr. John, a fifty-year-old teacher diagnosed with metastatic liver cancer.
Initially, Mr. John's cancer...
Cancer Stem Cells and Tumor Maintenance
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer Stem Cells and Tumor Maintenance
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Treatment Resistant Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Cancer Prevention
Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
Some...